October 2005
Leading experts present latest in cancer prevention research
Novel preventatives in diet, chemoprevention and genetic biomarkers
Baltimore, Md. – Leading cancer researchers will convene at the 4th Annual Frontiers in Cancer Prevention Research meeting of the American Association for Cancer Research (AACR), the premier gathering of its kind in the world, which features the latest developments in cancer prevention research.
The meeting will take place October 30 – November 2, 2005 in Baltimore, Maryland, and will focus on innovative research in the field of cancer prevention. Studies highlight diet, early intervention through new screening methods and lifestyle.
"Although there have been great strides in cancer treatment, the prevention of cancer is our goal in turning this life-threatening disease into a chronic illness," said William G. Nelson, V, M.D., Ph.D., of Johns Hopkins University and Program Chair of the meeting. "The integration of new technologies and medicines are improving our understanding of the preventive value of certain agents against cancers throughout the body."
To address prevention strategies and techniques, the meeting will highlight research that focuses on new developments such as targeted therapies, inflammation and cancer with a focus on COX-2 inhibitors, screening technologies, obesity and risk of cancer, and novel preventatives in the diet.
The meeting offers attendees a variety of sessions, including educational programs, talks on specific organ sites, a forum on the challenges of chemoprevention and the pharmaceutical industry, special events for young investigators, three poster sessions, and the Fourth Annual AACR-Cancer Research and Prevention Foundation Award Lecture for Excellence in Cancer Prevention Research.
"These studies give us hope for the future of cancer prevention. Our goal with this meeting is to educate the community about a broad range of the promising agents and strategies that are working in the fight against cancer," said Nelson.
Researchers will present exciting cancer prevention research to members of the media during a series of press briefings: - Monday, October 31
Novel Preventatives in Diet: 9:00 a.m. - 9:45 a.m.
* SPECIAL SESSION: New Cancer Vaccines: 10:30 a.m. - 11:15 a.m.
In this special press session, leading experts will share pioneering research offering evidence that cancer vaccines may be powerful preventatives against the onset of a number of cancers. Highlights will include updated findings about a new cervical cancer vaccine and successful data on a vaccine against HPV.
Oils, Fat, and Cancer: 1:00 p.m. - 1:45 p.m.
- Tuesday, November 1
Genetics and Biomarkers: 9:00 a.m. - 9:45 a.m.
Latest Evidence about Lowering Risk: 10:30 a.m. - 11:15 a.m.
Chemoprevention: 1:00 p.m. – 1:45 p.m.
- Wednesday, November 2
Tobacco and Nicotine: 8:30 a.m. - 9:15 a.m.
Founded in 1907, the American Association for Cancer Research is a professional society of more than 24,000 laboratory, translational, and clinical scientists engaged in all areas of cancer research in the United States and in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR's Annual Meetings attract nearly 16,000 participants who share new and significant discoveries in the cancer field. Specialty meetings, held throughout the year, focus on the latest developments in all areas of cancer research.